Acknowledgments
This work was supported by National Science Foundation (Nos.
1652992 and 1743426) as well as partially by the National Insti-
tutes of Health (NIH; R01NS102395). The content is solely the
responsibility of the authors and does not necessarily represent the
official views of the NIH.
References
1. Zomer
HD,
Vidane
AS,
Gonc¸alves
NN,
Ambro´sio
CE
(2015)
Mesenchymal
and
induced pluripotent stem cells: general insights
and clinical perspectives. Stem Cells Cloning
8:125–134
2. Rowe RG, Daley GQ (2019) Induced pluripo-
tent stem cells in disease modelling and drug
discovery. Nat Rev Genet 20:377–388
3. Yuan X, Rosenberg JT, Liu Y, Grant SC, Ma T
(2019) Aggregation of human mesenchymal
stem cells enhances survival and efficacy in
stroke treatment. Cytotherapy 21:1033–1048
4. Yuan X, Logan TM, Ma T (2019) Metabolism
in human mesenchymal stromal cells: a missing
link between hMSC biomanufacturing and
therapy? Front Immunol 10:977
5. The´ry C, Witwer KW, Aikawa E, Alcaraz MJ,
Anderson JD et al (2018) Minimal information
for studies of extracellular vesicles 2018: a posi-
tion statement of the International Society for
Extracellular
Vesicles
and
update
of
the
MISEV2014 guidelines. J Extracell Vesicles
7:1535750
6. Ding Q, Sun R, Wang P, Zhang H, Xiang M
et al (2018) Protective effects of human
induced pluripotent stem cell-derived exo-
somes on high glucose-induced injury in
human
endothelial
cells.
Exp
Ther
Med
15:4791–4797
7. Skamagki
M,
Zhang
C,
Ross
CA,
Ananthanarayanan A, Liu Z et al (2017) RNA
exosome complex-mediated control of redox
status in pluripotent stem cells. Stem Cell Rep
9:1053–1061
8. Hicks DA, Jones AC, Corbett NJ, Fisher K,
Pickering-Brown SM et al (2020) Extracellular
vesicles isolated from human induced pluripo-
tent stem cell-derived neurons contain a tran-
scriptional
network.
Neurochem
Res
45:1711–1728
9. Park K-S, Bandeira E, Shelke GV, L€asser C,
Lo¨tvall J (2019) Enhancement of therapeutic
potential of mesenchymal stem cell-derived
extracellular
vesicles. Stem Cell Res Ther
10:1–15
10. Sharma P, Mesci P, Carromeu C, McClatchy
DR, Schiapparelli L et al (2019) Exosomes
regulate neurogenesis and circuit assembly.
Proc Natl Acad Sci U S A 116:16086–16094
11. Clark K, Zhang S, Barthe S, Kumar P, Pivetti C
et al (2019) Placental mesenchymal stem cell-
derived extracellular vesicles promote myelin
regeneration in an animal model of multiple
sclerosis. Cell 8:1497
12. Li T, Yan Y, Wang B, Qian H, Zhang X et al
(2013) Exosomes derived from human umbili-
cal cord mesenchymal stem cells alleviate liver
fibrosis. Stem Cells Dev 22:845–854
13. Witwer KW, Van Balkom BW, Bruno S,
Choo A, Dominici M et al (2019) Defining
mesenchymal
stromal
cell
(MSC)-derived
small
extracellular
vesicles
for
therapeutic
applications. J Extracell Vesicles 8:1609206
14. Bai L, Shao H, Wang H, Zhang Z, Su C et al
(2017) Effects of mesenchymal stem cell-
derived exosomes on experimental autoim-
mune uveitis. Sci Rep 7(1):4323
15. Kordelas L, Rebmann V, Ludwig A, Radtke S,
Ruesing J et al (2014) MSC-derived exosomes:
a novel tool to treat therapy-refractory graft-
versus-host disease. Leukemia 28:970–973
16. Nassar W, El-Ansary M, Sabry D, Mostafa MA,
Fayad T et al (2016) Umbilical cord mesenchy-
mal stem cells derived extracellular vesicles can
safely ameliorate the progression of chronic
kidney diseases. Biomater Res 20:21
17. Kebriaei P, Isola L, Bahceci E, Holland K,
Rowley S et al (2009) Adult human mesenchy-
mal stem cells added to corticosteroid therapy
for the treatment of acute graft-versus-host
disease.
Biol
Blood
Marrow
Transplant
15:804–811
18. Lawson T, Kehoe DE, Schnitzler AC, Rapiejko
PJ, Der KA et al (2017) Process development
for expansion of human mesenchymal stromal
cells in a 50 L single-use stirred tank bioreactor.
Biochem Eng J 120:49–62
19. de Sousa PD, Bandeiras C, de Almeida FM,
Rodrigues CA, Jung S et al (2019) Scalable
manufacturing of human mesenchymal stromal
Human Stem Cell-derived Extracellular Vesicles in Bioreactors
203